39
Operating in a State of Control; A Risk-Based Approach to Quality EduQuest EDUcation: QUality Engineering, Science, & Technology Denise D. Dion Vice President Regulatory and Quality Services

Denise Dion, VP RA/QA Services EduQuest, and Former FDA Expert

Embed Size (px)

Citation preview

Page 1: Denise Dion, VP RA/QA Services EduQuest, and Former FDA Expert

Operating in a State of Control;

A Risk-Based Approach to Quality

EduQuest EDUcation: QUality Engineering, Science, & Technology

Denise D. Dion

Vice President Regulatory and Quality Services

Page 2: Denise Dion, VP RA/QA Services EduQuest, and Former FDA Expert

Design Controls

Material

Controls Records,

Documents, and

Change Controls

Equipment and

Facility Controls

Production and

Process Controls

Corrective and

Preventive

Actions

Management

Controls2

©2012 EduQuest, Inc.

Page 3: Denise Dion, VP RA/QA Services EduQuest, and Former FDA Expert

FDA Focus

• Management oversight

• Product life-cycle concept (cradle-to-grave)

• Conformance evidence – documentation

• Change Management

• Audits – overall quality system/design controls

• Corrective and Preventive Action system

3©2012 EduQuest, Inc.

Page 4: Denise Dion, VP RA/QA Services EduQuest, and Former FDA Expert

4©2012 EduQuest, Inc.

Page 5: Denise Dion, VP RA/QA Services EduQuest, and Former FDA Expert

5©2012 EduQuest, Inc.

Page 6: Denise Dion, VP RA/QA Services EduQuest, and Former FDA Expert

FDA Product Lifecycle

Draft Requirements

Prelim. Risk Assessment

Approved Requirements

510(k), PMA, PMA

supplement,

IDE, HDE, IRB

P1, early P2

6©2012 EduQuest, Inc.

Page 7: Denise Dion, VP RA/QA Services EduQuest, and Former FDA Expert

Pre-Market: Design

• Concept and Feasibility

– This is the time to determine the requirements of the

device

– Design starts once your initial requirements are

approvable

– Preliminary risk analysis (top-down) should be done

concurrent with determining your requirements

7©2012 EduQuest, Inc.

Page 8: Denise Dion, VP RA/QA Services EduQuest, and Former FDA Expert

The Yin/Yang of Design/CAPA

• Design is the beginning

• Risk Analysis – (product and process) begins with

Design

• Production and Post-Production Planning feeds the

CAPA system

8©2012 EduQuest, Inc.

Page 9: Denise Dion, VP RA/QA Services EduQuest, and Former FDA Expert

Cradle-to-Grave Concept

Design Controls

CAPA

Product

Monitoring

Complaints

Risk Management

Audits

Service Reports

9©2012 EduQuest, Inc.

Page 10: Denise Dion, VP RA/QA Services EduQuest, and Former FDA Expert

The Yin/Yang of Design/CAPA

• Production and Post-Production data is used to

– Assure our original risk assessments were correct

– Assist us in proper evaluation and investigation of

nonconformances (product, process, system)

– Identify needed actions to improve our product design,

processes and systems

10©2012 EduQuest, Inc.

Page 11: Denise Dion, VP RA/QA Services EduQuest, and Former FDA Expert

The Yin/Yang of Design/CAPA

• In deciding on requirements for design changes or new

designs

– Marketing data

– Voice of the Customer

– Human Factors

– Regulatory/Standards

– Production/Post-production data from similar designs

11©2012 EduQuest, Inc.

Page 12: Denise Dion, VP RA/QA Services EduQuest, and Former FDA Expert

Use of Trace Matrices

• Use trace matrices

– To help identify affected parts of design when changes

are made

– To Identify tests to be repeated on changed design

• To understand where you may be introducing new risks

or failure modes or affecting existing mitigations

12©2012 EduQuest, Inc.

Page 13: Denise Dion, VP RA/QA Services EduQuest, and Former FDA Expert

Design Input Requirements

• Initial Design Input Requirements include:

– User needs

– Intended uses

– Safety attributes

– Performance features or usability (Human

Factors)

– Technical compatibility, Standards

13©2012 EduQuest, Inc.

Page 14: Denise Dion, VP RA/QA Services EduQuest, and Former FDA Expert

Design Inputs – Sources

• Human Factors

• Regulations

• Standards

• Guidance

• Preliminary Risk Assessment activities

• Failure Investigations of Complaints, MDRs,

CAPAs, Recalls (Yours and Others)

• Marketing and Clinical studies and surveys

14©2012 EduQuest, Inc.

Page 15: Denise Dion, VP RA/QA Services EduQuest, and Former FDA Expert

Design Input and Outputs

• Initial Design Input Requirements

– What we design to

• Final Design Output Specifications – the

Device Master Record

– What we build to

15©2012 EduQuest, Inc.

Page 16: Denise Dion, VP RA/QA Services EduQuest, and Former FDA Expert

Design and Usability Goals

• Design for the most common users and tasks

– 80% of users and tasks

– Users, not engineers

• Make information easily obtainable (intuitive)

– Memory is fallible

©2012 EduQuest, Inc. 19

Page 17: Denise Dion, VP RA/QA Services EduQuest, and Former FDA Expert

Design and Usability Goals

• Provide obvious error control

– Prevent errors

– Make errors recognizable

– Enable immediate error recovery

©2012 EduQuest, Inc. 20

Page 18: Denise Dion, VP RA/QA Services EduQuest, and Former FDA Expert

Consequences of Poor Usability

• Use Error – complaints, recalls

• Increased technical support costs

• Increased training requirements

• Revision of User Manual

(possible FDA submission)

©2012 EduQuest, Inc. 21

Page 19: Denise Dion, VP RA/QA Services EduQuest, and Former FDA Expert

Why Design Input is Important

• Garbage In – Garbage Out (GIGO)

2012 EduQuest, Inc.22

Page 20: Denise Dion, VP RA/QA Services EduQuest, and Former FDA Expert

Consequences of

Inadequate Design Input

• Device not fit for its intended use

– Not effective

– Not safe

• Complaints, MDRs, Recalls

• Changes – design, manufacturing process

• FDA Regulatory Action

©2012 EduQuest, Inc. 23

Page 21: Denise Dion, VP RA/QA Services EduQuest, and Former FDA Expert

Design and Risk Management

• Perform initial (top-down) risk assessment during the

creation of the initial design input requirements.

• Perform final risk assessment (bottom-up) to help finalize

your design output specifications contained in the device

master record.

• For pre-market knowing frequency of occurrence of harm

may be enough;

• For post-market you will also need frequency of

occurrence of the event or failure mode.

©2012 EduQuest, Inc.24

Page 22: Denise Dion, VP RA/QA Services EduQuest, and Former FDA Expert

Post-Market: CAPA

• An effective CAPA system uses mechanisms to monitor

the quality of people, processes, product, and quality

system

• This includes complaint handling, nonconforming

product mechanisms, adverse event reporting,

corrections, removals, and recalls

• Need to understand product and process risk to make

appropriate decisions

22©2012 EduQuest, Inc.

Page 23: Denise Dion, VP RA/QA Services EduQuest, and Former FDA Expert

Purpose of a CAPA System

• To collect and analyze quality information - feedback

• Identify and investigate product and quality problems

• Take appropriate and effective corrective and preventive

actions to prevent their occurrence

or recurrence

23©2012 EduQuest, Inc.

Page 24: Denise Dion, VP RA/QA Services EduQuest, and Former FDA Expert

CAPA Data Sources – Quality Data

• Customer complaints

• Incoming components

/Materials

• Inspection/test data

“final”

• Inspection/test data

“in process”

• Calibration

• Record/document issues

• Nonconforming material

or product

• Supplier audits

• Management review

• 3rd party audits

• Internal audits

24©2012 EduQuest, Inc.

Page 25: Denise Dion, VP RA/QA Services EduQuest, and Former FDA Expert

CAPA Data Sources – Quality Data

• Process control data

• FDA observations

• Process Validation issues

• Facility control

• Training records

• Design Verification

/Validation

• Device history records

• Field actions (corrections

and removals)

• Equipment maintenance

• Change control records

• Scrap/rework/yield data

• Environmental

monitoring/control

25©2012 EduQuest, Inc.

Page 26: Denise Dion, VP RA/QA Services EduQuest, and Former FDA Expert

CAPA Data Sources – Quality Data

• Returned goods

• Medwatch/MDR/

Vigilance reports

• Handling/storage of

product data

• Field service reports

• Clinical data

• Employee complaints

• Product warranty

• Clinical literature and

journal articles

• Legal claims

26©2012 EduQuest, Inc.

Page 27: Denise Dion, VP RA/QA Services EduQuest, and Former FDA Expert

CAPA Procedures

• Procedures that discuss how any nonconformance

or complaint is initially evaluated for validity,

extent and impact

• Procedures that state when a root cause

investigation is required for all data sources as

well as for trends – criteria for escalation

• Procedures to describe how root cause

investigations are to be conducted and documented

27©2012 EduQuest, Inc.

Page 28: Denise Dion, VP RA/QA Services EduQuest, and Former FDA Expert

28

General Flow for a CAPA System

Nonconformance

Product Process or System

Potential or Actual

Potential NC Report

Process or Quality NC Report

Non-complaint

NCMR

Level 2 FI?

Level 1 FI

Document Corrections for all existing and trend all

Trend Analysis Indicates Actual or Potential Non-conformance

Enter Into CAPA Database

Document and Track through Implementation and Effectiveness

Complaint

CAPA?

Level 1 FI

Level 2 FI?

Close

Trend Analysis Indicates Actual or Potential Non-conformance

Level 2 FI

Potential Actual

No

Yes

No Yes

Yes

No

Level 2 FI

Document and Trend

©2012 EduQuest, Inc.

Page 29: Denise Dion, VP RA/QA Services EduQuest, and Former FDA Expert

CAPA System Advice

• Not every situation can be a code red

• Use risk management to prioritize Non-conformance and

CAPA work

29©2012 EduQuest, Inc.

Page 30: Denise Dion, VP RA/QA Services EduQuest, and Former FDA Expert

Key Phases of Investigations

• Three key phases (some companies break these out into

more than three)

– Investigation (to assess whether the observed result is

valid, extent and impact)

– Expanded investigation (to assess cause)

– Corrective action (to identify action(s) to correct the

cause of the problem and ensure the nonconformity

cannot recur)30©2012 EduQuest, Inc.

Page 31: Denise Dion, VP RA/QA Services EduQuest, and Former FDA Expert

Key Objectives of Initial Evaluation

• To determine if the observed result is valid

• To determine its impact or significance

• To determine the extent of the problem

– Other lots or serial numbers of that product

– Related products and processes

31©2012 EduQuest, Inc.

Page 32: Denise Dion, VP RA/QA Services EduQuest, and Former FDA Expert

FDA Guidance

• “To be meaningful, the investigation should be

thorough, timely, unbiased, well-documented, and

scientifically defensible.”

– Note − this is an excellent starting checklist for

reviewing and challenging draft investigation reports

32©2012 EduQuest, Inc.

Page 33: Denise Dion, VP RA/QA Services EduQuest, and Former FDA Expert

SOAP

• S – Subjective data – at input, initial evaluation

• O – Objective data – initial evaluation and root

cause investigation

• A – Assessment – probable or actual cause

– Rule Out – what it definitely, maybe is not

• P – Plan – corrections, containment, corrective or

preventive actions, additional actions

33©2012 EduQuest, Inc.

Page 34: Denise Dion, VP RA/QA Services EduQuest, and Former FDA Expert

Corrective and Preventive Action

• Need to both –

– Treat the symptoms

• Design and implement corrective actions for

each cause

– Cure the related diseases

• Thorough and exhaustive root cause analysis

• Design and implement additional corrective or

preventive actions to ensure that the problem

cannot recur or occur

34©2012 EduQuest, Inc.

Page 35: Denise Dion, VP RA/QA Services EduQuest, and Former FDA Expert

Cradle-to-Grave Concept

Design Controls

CAPA

Product

Monitoring

Complaints

Risk Management

Audits

Service Reports

35©2012 EduQuest, Inc.

Page 36: Denise Dion, VP RA/QA Services EduQuest, and Former FDA Expert

EduQuestEDUcation: QUality Engineering, Science and Technology

• Global team of FDA compliance experts based near

Washington, DC

• Founded by former senior officials & investigators from

FDA’s Office of Regulatory Affairs (ORA)

Headquarters

• Advising medical device and bio-pharmaceutical

companies worldwide since 1995

• Focus on Audits and Training for Quality Systems, Risk

Management, Part 11, Validation, Inspection Readiness

©2012 EduQuest, Inc. 39

Page 37: Denise Dion, VP RA/QA Services EduQuest, and Former FDA Expert

Denise DionVice President,

Regulatory & Quality Services

EduQuest

• 18 years of experience with the U.S. FDA Office of Regulatory

Affairs (ORA)

• Former FDA Medical Device Expert Investigator

• Developed many of FDA’s inspection guidance and training

materials

• Primary editor of the FDA Investigations Operations Manual

(IOM) – the “bible” for FDA inspectors

• Lead instructor for EduQuest CAPA, QSR Basics, and Design

Control classroom training courses (www.EduQuest.net)©2012 EduQuest, Inc.

40

Page 38: Denise Dion, VP RA/QA Services EduQuest, and Former FDA Expert

EduQuestEDUcation: QUality Engineering, Science and Technology

Additional Opportunity for Staff Training from EduQuest:

The CAPA Confidence Clinic:

Effective CAPA Systems, Failure Investigations & Complaint Management

• September 27-28, 2012 – Frederick, MD (near Baltimore and Washington, DC)

QSR Compliance Basics:

Complying with FDA’s Medical Device 21 CFR 820 Quality System Regulation

• October 16-17, 2012 – Frederick, MD (near Baltimore and Washington, DC)

Design Control for Medical Devices:

Meeting FDA’s 21 CFR 820.30 Rules for Quality Design and Manufacturing

• October 17-20, 2012 – Frederick, MD (near Baltimore and Washington, DC)

Details at www.EduQuest.net Or Email: [email protected]

2012 EduQuest, Inc.41

Page 39: Denise Dion, VP RA/QA Services EduQuest, and Former FDA Expert

Questions

or Comments?

Contact: [email protected]; 240-449-5852

EduQuest, Inc.

1896 Urbana Pike, Suite 14

Hyattstown, MD 20871

+1 (301) 874-6031

[email protected]

www.EduQuest.net

©2012 EduQuest, Inc. 42